HOME >> BIOLOGY >> NEWS
Diabetes tied to altering of the heart's circadian clock

New Orleans, LA -- A new research study has found that diabetes, the cause of numerous heart disorders, likely disrupts the organ's circadian clock. This could lead to the heart failing to initiate important stimuli to several internal and external environmental changes, thereby contributing to heart failure.

Some 143 million patients worldwide are diagnosed with diabetes, almost five times more than estimates of ten years ago. Heart disease, often presenting as disease of the heart muscle (cardiomyopathy) is the leading cause of death among patients with diabetes mellitus. Diabetes, in turn, is the disease most associated with heart failure, and adversely affects outcomes of cardiovascular disease.

Background

Nearly 300 years ago, researchers found that almost all cells possess some kind of intrinsic and self-sustained "clocks" allowing perception of the time of day, independent of external influences. These internal clocks provide the selective advantage of anticipation, allowing an organism to prepare for an expected "stimulus" (such as activity, feeding, or light intensity for a photosynthetic organism) at a given time of the day. In order to maintain their advantageous nature, clocks are reset by environmental cues known as "zeitgebers," that enable the organism to become synchronized with its surroundings.

Mammals possess both a central clock numerous peripheral clocks. The former is located in the suprachiasmatic nucleus (SCN) where a central pacemaker perceives light signals via the retina, which resets its mechanism. Peripheral clocks are those clocks located within other regions of the organism besides the SCN. The central and peripheral clocks require synchronization; zeitgebers involved in the process are light for the central clock, and neurohumoral factors for the peripheral clocks. Several candidates have been suggested as the zeitgebers for peripheral clocks, including glucocorticoids, retinoic acid and melaton
'"/>

Contact: Donna Krupa
703-967-2751
American Physiological Society
22-Apr-2002


Page: 1 2 3 4

Related biology news :

1. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
2. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
3. Joslin Diabetes Center launches research section on developmental and stem cell biology
4. Joslin Diabetes Center releases new low impact exercise video
5. As obesity skyrockets, Joslin Diabetes Center urges action to stem the tide of type 2 diabetes
6. Diabetes drug may be new tool in treating breast cancer
7. Diabetes in the elderly linked to fewer cellular power plants
8. Diabetes therapies and liquid memory may develop from micro fluid research, Science researchers say
9. Bacteria From Gum Infections Associated With Diabetes, Chronic Lung Disease, UB Studies Find
10. New Findings On Receptor Regulation May Lead To Better Drugs For Diabetes
11. Researchers Identify And Isolate First Gene For A Form Of Insulin-Dependent Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... ... Brilliant , the leading smart home control and lighting company, today ... purchase in the U.S., Canada, and Puerto Rico through ADI Global Distribution, a leading ... being available for purchase through ADI’s Digital Branch , Brilliant products are now ...
(Date:9/3/2020)... ... 03, 2020 , ... Litmus Health , the research-ready ... of the company’s security practices has been completed. The assessment deemed Litmus infrastructure ... evaluation reviewed Litmus’ processes and systems, assessing them to see whether they adhere ...
(Date:8/26/2020)... ... August 24, 2020 , ... Elgia Therapeutics , a ... diseases, today announced that Dr. Stacie Canan has joined the company as its ... served as Executive Director of Global Health at Bristol Myers Squibb (formerly Celgene), ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... LEXINGTON, Mass. (PRWEB) , ... August 11, 2020 ... ... awarded $300,000 a year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial ... year in 2021 and 2022. The network is a consortium of academic research ...
(Date:8/12/2020)... ... August 12, 2020 , ... Inc. magazine today ... leader in FDA compliance consulting has been named on its annual Inc. 5000 ... represents a unique look at the most successful companies within the American economy’s ...
(Date:8/3/2020)... PHILADELPHIA (PRWEB) , ... August 03, 2020 , ... ... data collection, today announced Jim Corrigan, President and CEO has been named one ... a broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
Breaking Biology Technology:
Cached News: